| 1 |
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial
|
|
|
|
In: ISSN: 1745-6215 ; Trials ; https://hal.sorbonne-universite.fr/hal-02407657 ; Trials, BioMed Central, 2019, 20 (1), pp.632. ⟨10.1186/s13063-019-3613-z⟩ (2019)
|
|
BASE
|
|
Show details
|
|
|
| 2 |
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial
|
|
|
|
BASE
|
|
Show details
|
|
|
| 3 |
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial
|
|
|
|
BASE
|
|
Show details
|
|
|
| 4 |
Structural, Microstructural, and Metabolic Alterations in Primary Progressive Aphasia Variants
|
|
|
|
In: ISSN: 1664-2295 ; Frontiers in Neurology ; https://hal.inria.fr/hal-01897015 ; Frontiers in Neurology, Frontiers, 2018, 9, ⟨10.3389/fneur.2018.00766⟩ (2018)
|
|
BASE
|
|
Show details
|
|
|
| 5 |
Structural, microstructural and metabolic alterations in Primary Progressive Aphasia variants
|
|
|
|
In: Annual meeting of the Organization for Human Brain Mapping - OHBM 2018 ; https://hal.inria.fr/hal-01764289 ; Annual meeting of the Organization for Human Brain Mapping - OHBM 2018, Jun 2018, Singapore, Singapore (2018)
|
|
BASE
|
|
Show details
|
|
|
| 6 |
Parietal involvement in the semantic variant of primary progressive aphasia with Alzheimer's disease CSF profile
|
|
|
|
In: ISSN: 1387-2877 ; Journal of Alzheimer's Disease ; https://hal.sorbonne-universite.fr/hal-01928504 ; Journal of Alzheimer's Disease, IOS Press, 2018, 66 (1), pp.271 - 280. ⟨10.3233/JAD-180087⟩ (2018)
|
|
BASE
|
|
Show details
|
|
|
| 7 |
An Automated Pipeline for the Analysis of PET Data on the Cortical Surface
|
|
|
|
In: ISSN: 1662-5196 ; Frontiers in Neuroinformatics ; https://hal.inria.fr/hal-01950933 ; Frontiers in Neuroinformatics, Frontiers, 2018, 12, ⟨10.3389/fninf.2018.00094⟩ (2018)
|
|
BASE
|
|
Show details
|
|
|
| 8 |
An Automated Pipeline for the Analysis of PET Data on the Cortical Surface
|
|
|
|
BASE
|
|
Show details
|
|
|
| 9 |
Structural, Microstructural, and Metabolic Alterations in Primary Progressive Aphasia Variants
|
|
|
|
BASE
|
|
Show details
|
|
|
| 10 |
Imagerie hybride TEP/IRM dans le bilan des pathologies neurodégénératives : retour d’expérience
|
|
|
|
In: 2es Journées Francophones de Médecine Nucléaire ; https://hal.inria.fr/hal-01427374 ; 2es Journées Francophones de Médecine Nucléaire, May 2016, Grenoble, France. pp.169 - 170, ⟨10.1016/j.mednuc.2016.03.003⟩ (2016)
|
|
BASE
|
|
Show details
|
|
|
| 11 |
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 12, iss 3 (2016)
|
|
BASE
|
|
Show details
|
|
|
| 12 |
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 12, iss 3 (2016)
|
|
BASE
|
|
Show details
|
|
|
| 13 |
Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria
|
|
Dubois, Bruno; Hampel, Harald; Feldman, Howard H.; Scheltens, Philip; Aisen, Paul; Andrieu, Sandrine; Bakardjian, Hovagim; Benali, Habib; Bertram, Lars; Blennow, Kaj; Broich, Karl; Cavedo, Enrica; Crutch, Sebastian; Dartigues, Jean-François; Duyckaerts, Charles; Epelbaum, Stéphane; Frisoni, Giovanni B.; Gauthier, Serge; Genthon, Remy; Gouw, Alida A.; Habert, Marie-Odile; Holtzman, David M.; Kivipelto, Miia; Lista, Simone; Molinuevo, José-Luis; O’Bryant, Sid E.; Rabinovici, Gil D.; Rowe, Christopher; Salloway, Stephen; Schneider, Lon S.; Sperling, Reisa; Teichmann, Marc; Carrillo, Maria C.; Cummings, Jeffrey; Jack, Cliff R.. - 2016
|
|
Abstract:
During the past decade, a conceptual shift occurred in the field of Alzheimer’s disease (AD) considering the disease as a continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible to identify the disease even at the preclinical stage before the occurrence of the first clinical symptoms. This preclinical stage of AD has become a major research focus as the field postulates that early intervention may offer the best chance of therapeutic success. To date, very little evidence is established on this “silent” stage of the disease. A clarification is needed about the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage. This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations.
|
|
Keyword:
Article
|
|
URL: https://doi.org/10.1016/j.jalz.2016.02.002
http://www.ncbi.nlm.nih.gov/pubmed/27012484
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417794/
|
|
BASE
|
|
Hide details
|
|
|
| 14 |
Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia
|
|
|
|
BASE
|
|
Show details
|
|
|
|
|
